We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Redox Potential Used as a Feasible Marker for Banked Blood Quality

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Stored red blood cells (RBCs) may undergo oxidative stress over time, with functional changes affecting oxygen delivery. Central to these changes are oxidation-reduction (redox) reactions and redox potential (RP) that must be maintained for cell function.

Despite the seeming importance and implications of utilizing RP measures, there are currently few means by which to make the measurement directly, and most investigators have relied historically on isolated redox species and secondary markers of oxidative stress such as glutathione couples, malondialdehyde, and estimates of oxidative injury in processed samples.

Biomedical Engineers at the University of Michigan (Ann Arbor, MI, USA) investigated changes in RP over time in banked RBCs, and among RBCs of similar age. The scientists tested multiple random RBC segments from RBC units were tested (n = 32), ranging in age from five to 40 days, at 5-day intervals. RP was recorded by measuring open circuit potential of RBCs using nanoporous gold electrodes with Ag/AgCl reference. RP measures were also performed on peripheral venous blood from 10 healthy volunteers. RP measures were compared between RBC groups, and with volunteer blood.

Direct measurement of RP was performed by measuring open circuit potential of the RBC sample via the np gold electrode, with Ag/AgCl reference, using a ParstatMC multi-potentiostat (Princeton Applied Research, Berwyn, PA, USA). The investigators reported that stored RBCs show time-dependent RP increases. There were significant differences in Day 5 RP compared to all other groups, Day 10–15 versus ages ≥ Day 20, Day 20–25 versus Day 40, and all groups compared to healthy volunteers. RP became more positive over time suggesting ongoing oxidation as RBCs age; however, storage time alone was not predictive of RP measured in a particular unit/segment.

The authors concluded that there were significant differences in RP between freshly stored RBCs and all others, with RP becoming more positive over time. However, storage time alone does not predict RP, indicating RP screening may be important independent of age and may serve as a marker of RBC health. Targeting RP may enable the use of antioxidant therapies to restore RP balance in stored RBCs, as well as systemically in those receiving multiple transfusions, improving the clinical effectiveness of RBCs and potentially reducing associated morbidities. The study was published on August 23, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
University of Michigan
Princeton Applied Research


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.